Benefits and costs of HIV testing

作者: D. Bloom , S Glied

DOI: 10.1126/SCIENCE.1829547

关键词:

摘要: The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points view: that private employers whose profitability may be affected by their policies public policy-makers who affect social welfare through design regulations related to HIV testing. results reveal is clearly not cost-beneficial for most firms, although the outweigh some large firms offer generous fringe-benefit packages recruit workers populations which prevalence infection high. analysis also indicates decisions unregulated likely yield socially optimal economic outcomes existing state federal legislation has been motivated primarily concerns over equity.

参考文章(10)
D. Bloom, G Carliner, The economic impact of AIDS in the United States Science. ,vol. 239, pp. 604- 610 ,(1988) , 10.1126/SCIENCE.3277273
Donald S. Burke, John F. Brundage, Robert R. Redfield, James J. Damato, Charles A. Schable, Pamela Putman, Robert Visintine, Howard I. Kim, Measurement of the False Positive Rate in a Screening Program for Human Immunodeficiency Virus Infections New England Journal of Medicine. ,vol. 319, pp. 961- 964 ,(1988) , 10.1056/NEJM198810133191501
David E. Bloom, Sherry Glied, The evolution of AIDS economic research. Health Policy. ,vol. 11, pp. 187- 196 ,(1989) , 10.1016/0168-8510(89)90035-3
Paul A. Volberding, Stephen W. Lagakos, Matthew A. Koch, Carla Pettinelli, Maureen W. Myers, David K. Booth, Henry H. Balfour, Richard C. Reichman, John A. Bartlett, Martin S. Hirsch, Robert L. Murphy, W. David Hardy, Ruy Soeiro, Margaret A. Fischl, John G. Bartlett, Thomas C. Merigan, Newton E. Hyslop, Douglas D. Richman, Fred T. Valentine, Lawrence Corey, , Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter The New England Journal of Medicine. ,vol. 322, pp. 941- 949 ,(1990) , 10.1056/NEJM199004053221401
JeffreyA Golden, Harry Hollander, David Chernoff, David Feigal, JohnE Conte, Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. The Lancet. ,vol. 333, pp. 654- 657 ,(1989) , 10.1016/S0140-6736(89)92153-3
James E. Long, Frank A. Scott, The Income Tax and Nonwage Compensation The Review of Economics and Statistics. ,vol. 64, pp. 211- 219 ,(1982) , 10.2307/1924300
LauraJ. Fehrs, LaurenceR. Foster, Victor Fox, David Fleming, RobertO. McAlister, Steven Modesitt, Robert Conrad, Trial of anonymous versus confidential human immunodeficiency virus testing. The Lancet. ,vol. 332, pp. 379- 382 ,(1988) , 10.1016/S0140-6736(88)92846-2
GODFRIED J. P. VAN GRIENSVEN, E. M. M. DE VROOME, ROBERT A. P. TIELMAN, JAAP GOUDSMIT, FRANK DE WOLF, JAN VAN DER NOORDAA, ROEL A. COUTINHO, EFFECT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIBODY KNOWLEDGE ON HIGH-RISK SEXUAL BEHAVIOR WITH STEADY AND NONSTEADY SEXUAL PARTNERS AMONG HOMOSEXUAL MEN American Journal of Epidemiology. ,vol. 129, pp. 596- 603 ,(1989) , 10.1093/OXFORDJOURNALS.AJE.A115172
David P. Hamilton, AID Aids AIDS Efforts with New Syringes Science. ,vol. 249, pp. 20- ,(1990) , 10.1126/SCIENCE.249.4964.20